Company / AR per Share
Tandem Diabetes Care AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.50
FY2025
5-year range
$1.64 / $2.50
FY2021-FY2025
Trend
+42.9%
vs FY2024
Sector context
#83 of 136
Health Care
What the data says
At $2.50, Tandem Diabetes Care's ar per share ranks #83 of 136 in the Health Care sector. AR per Share has fluctuated over the past 10 years, ranging from $0.37 in FY2016 to $6.69 in FY2017.
Based on SEC 10-K filings.
2.50 in FY2025 with a 5-year CAGR of +12.5%.
Improved from $1.64 to $2.50 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
#83 of 136 in Health CareTop 61% of 136This company $2.50 Sector average $12.05
▼
-79.3% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 42.9% year-over-year.
- Ranks #83 out of 136 companies in the Health Care sector.
- Peak ar per share was recorded in FY2017.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.50 | +42.9% |
| FY2024 | $1.75 | +6.8% |
| FY2023 | $1.64 | -9.0% |
| FY2022 | $1.80 | +1.2% |
| FY2021 | $1.78 | +28.4% |
| FY2020 | $1.38 | +71.0% |
| FY2019 | $0.81 | -76.7% |
| FY2018 | $3.48 | -48.0% |
| FY2017 | $6.69 | +1710.6% |
| FY2016 | $0.37 | -37.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026